WP
AGN

WealthPLAN Partners’s Allergan plc AGN Stock Holding History

WealthPLAN Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-16,261
Closed -$2.5M – 281
2018
Q3 		$2.5M Buy
16,261
+949
+6% +$174K 0.46% 63
2018
Q2 		$2.55M Buy
15,312
+1,141
+8% +$183K 0.52% 57
2018
Q1 		$2.38M Buy
14,171
+2,022
+17% +$339K 0.52% 53
2017
Q4 		$1.99M Sell
12,149
-2,061
-15% -$370K 0.53% 50
2017
Q3 		$2.91M Buy
14,210
+467
+3% +$109K 0.82% 33
2017
Q2 		$3.34M Buy
13,743
+13,294
+2,961% +$3.12M 0.96% 26
2017
Q1 		$107K Buy
+449
New +$105K 0.37% 51
2016
Q3 		$864K Sell
3,663
-3,647
-50% -$891K 0.28% 58
2016
Q2 		$845K Buy
+7,310
New +$1.69M 0.11% 128
2015
Q4 		$1.12M Buy
+10,767
New +$3.21M 0.18% 90
2015
Q2 		$1.09M Sell
3,610
-7
-0.2% -$2.09K 0.48% 31
2015
Q1 		$1.08M Buy
+3,617
New +$1.03M 0.5% 39

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

WealthPLAN Partners's AGN Position: Q4 2018 in Review

WealthPLAN Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 16,261 shares — an estimated $2.5M sold.

WealthPLAN Partners first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $3.34M in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • WealthPLAN Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • WealthPLAN Partners sold 16,261 Allergan plc shares in Q4 2018, an estimated $2.5M.
  • WealthPLAN Partners first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • WealthPLAN Partners's Allergan plc position peaked at $3.34M in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on WealthPLAN Partners's 13F filing for Q4 2018, filed 20 Feb 2019.